போது தி சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from போது தி சீரம் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In போது தி சீரம் நிறுவனம் Today - Breaking & Trending Today

Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages"

Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages"
dnaindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dnaindia.com Daily Mail and Mail on Sunday newspapers.

United States , Randeep Guleria , Albert Bourla , While The Serum Institute , India Chamber , United States India Chamber , Serum Institute , ஒன்றுபட்டது மாநிலங்களில் , ரந்தீப் குலேரியா , போது தி சீரம் நிறுவனம் , இந்தியா அறை , ஒன்றுபட்டது மாநிலங்களில் இந்தியா அறை , சீரம் நிறுவனம் ,

Profits of doom: How India's black market has thrived on misery during its second wave of Covid

Don t show me this message again✕
When Kanika Saxena transferred Rs 18,000 (£173) to a man to get Remdesivir injections for a Covid-19 patient who was in a critical condition, little did she know that she would end up being cheated.
“We waited seven hours for this man to deliver the injections. I tried calling him from at least nine, ten different numbers, but he never picked up. He stopped responding to texts after I sent him a screenshot showing that the money had been transferred to his account,” she said.
This is not an isolated incident in India, a country that has been overwhelmed by a deadly second wave of the virus as its healthcare system crumbles. Hospitals have been sending SOS messages about the shortage of oxygen, while patients are left unattended as beds run out, and people are forced to obtain medical supplies using their own resources. ....

Uttar Pradesh , Tamil Nadu , Rijom John , Damulya Nidhi , Naresh Trehan , Jan Swasthya Abhiyan , Praveen Josyula , Bobby Vijayan , K Rajasekharan Nayar , Narendra Modi , Indranil Mukherjee , Saloni Sharma , Randeep Guleria , Kanika Saxena , Global Institute Of Public Health , Central University Of Tamil Nadu , Rajagiri College Of Social Sciences , While The Serum Institute , Serum Institute Of India , India Institute Of Medical Sciences , Jan Swasthya , Central University , All India Institute , Medical Sciences , Global Institute , Public Health ,

SII to seek WHO's approval for supplying 200 million doses of Covid vaccines to GAVI-COVAX alliance

SII to seek WHO s approval for supplying 200 million doses of Covid vaccines to GAVI-COVAX alliance
SII to seek WHO s approval for supplying 200 million doses of Covid vaccines to GAVI-COVAX alliance
The Serum Institute of India (SII) has also announced that it will sell doses of its Covid-19 vaccine Covishield to the Centre at Rs 200 per dose while the same will be sold at Rs 1,000 per dose in the private market.
advertisement
UPDATED: January 12, 2021 19:27 IST
Trucks being used to transport Covishield from SII s facility in Pune s Pimpri Chinchwad (Photo Credits: PTI)
One of the world s largest vaccine makers, Pune-based Serum Institute of India (SII) will supply 200 million doses of its Covid-19 vaccine to the WHO s GAVI-COVAX alliance in the next few weeks, sources told India Today. ....

Oxford Astrazeneca Covishield , Tedros Ghebreyesus , Adar Poonawalla , Adar Poonawala , Serum Institute , While The Serum Institute , Melinda Gates Foundation , Serum Institute Of India , World Health Organisation , Pune Based Serum Institute , World Health , India Today , Melinda Gates , Business Today , Who 039s Gavi Covax Alliance , Sii Who Vaccine , Sii Covishield Vaccine , Sii Covid Vaccine , Who Vaccine Alliance , அடார் பூனாவல்ல , அடார் பூனாவள , சீரம் நிறுவனம் , போது தி சீரம் நிறுவனம் , மெலிண்டா வாயில்கள் அடித்தளம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,

How will Oxford vaccine be made in India? Exclusive peek inside Serum Institute's Covishield plant

How will Oxford vaccine be made in India? Exclusive peek inside Serum Institute s Covishield plant
How will Oxford vaccine be made in India? Exclusive peek inside Serum Institute s Covishield plant
India Today TV s Rahul Kanwal visited the Serum Institute in Pune where millions of Covishield viles are being produced, packaged and stored as we speak. The institute’s CEO Adar Poonawalla took Rahul Kanwal for an exclusive walkabout around the Covishield factory to show and explain that process.
advertisement
UPDATED: January 3, 2021 12:59 IST
SII CEO Adar Poonawalla took India Today TV’s Rahul Kanwal for an exclusive tour of the factory making Covishield – the Oxford Covid-19 vaccine ....

Adar Poonawalla , Rahul Kanwal , Adar Poonwalla , Astrazeneca Oxford University , Serum Institute , While The Serum Institute , Serum Institute Of India , Central Drugs Standard Control Organisation , Pune Based Serum Institute , India Today , அடார் பூனாவல்ல , ராகுல் கன்வால் , சீரம் நிறுவனம் , போது தி சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , புனே அடிப்படையிலானது சீரம் நிறுவனம் , இந்தியா இன்று ,